Document:

20-F

EXHIBIT 10.1  

CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM 

We consent to the incorporation by
reference in the Registration Statements (Form S-8 File No. 333-10840; Form S-8 File No.
333-12814; Form S-8 File No. 333-13186; Form S-8 File No. 333-91650; Form S-8 File No.
333-122128) of Optibase Ltd. of our report, dated January 31, 2006, with respect to the
consolidated financial statements of Optibase Ltd., included in the Annual
Report (Form 20-F) for the year ended December 31, 2005. 

		
		
		
		
		
	Tel-Aviv, Israel	KOST FORER GABBAY & KASIERER
	April 12, 2006	A Member of Ernst & Young GlobalCertificate of Incorporation of the Registrant

 Exhibit 4.1 
 CERTIFICATE OF INCORPORATION 
 OF 
 ANTARES PHARMA, INC. 
 The undersigned, a natural person of full age, for the
purpose of forming a corporation under the General Corporation Law of the State of Delaware, does hereby adopt the following Certificate of Incorporation: 
 ARTICLE I 
 The name of the Corporation is Antares Pharma, Inc. 
 ARTICLE II 
 The address of the
Corporation’s registered office in the State of Delaware is c/o The Corporation Trust Company, 1209 Orange Street in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corporation Trust
Company. 
 ARTICLE III 
 The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL. 
 ARTICLE IV 
 CAPITAL STOCK 
 The total number of shares of capital stock which the Corporation shall have authority to issue is One Hundred Three Million (103,000,000) shares, consisting of 100,000,000 shares of common stock, par value $0.01
per share (“Common Stock”) and 3,000,000 shares of preferred stock, par value $0.01 per share (“Preferred Stock”). 
 The
powers, preferences and rights of, and the qualifications, limitations and restrictions upon, each class or series of stock shall be determined in accordance with, or as set forth below in, this Article IV. 
 A. COMMON STOCK 
 (a) Voting
Rights. The holders of the Common Stock shall have the exclusive right to vote for the election of directors of the Corporation (the “Directors”) and on all other matters requiring stockholder action, each outstanding share entitling
the holder thereof to one vote on each matter properly submitted to the stockholders of the Corporation for their vote. Except as otherwise required by law or expressly provided in this Certificate, the holders of shares of Common and Preferred
shall vote together and not as separate classes or series. 
 (b) Dividends. Except as otherwise provided by law or this Certificate
and subject to the preferential rights of holders of Preferred, dividends may be declared and paid or set apart for payment upon the Common Stock out of any assets or funds of the Corporation legally available for 

  

 1 

 
the payment of dividends, but only when and as declared by the Board or any authorized committee thereof. 
 (c) Liquidation Rights. Upon the voluntary or involuntary liquidation, dissolution or winding up of the Corporation, whether voluntary or
involuntary, after payment or provision for payment of the debts and other liabilities of the Corporation and any preferential or other amounts to which the holders of any outstanding shares of Preferred shall be entitled, the net assets of the
Corporation shall be distributed pro rata to the holders of the Common Stock. 
 B. PREFERRED STOCK 
 The shares of Preferred may be issued from time to time in one or more series. The Board of Directors of the Corporation is authorized, subject to
limitations prescribed by law and the provisions of this Article IV, to provide for the issuance of the shares of Preferred Stock in one or more series, by filing a certificate pursuant to the applicable laws of the State of Delaware, to establish
from time to time the number of shares to be included in each such series, and to fix the designations, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. 
 ARTICLE V 
 INCORPORATOR

 The name and mailing address of the incorporator is as follows: 
 Jeffrey L. Cotter, Esq. 
 Leonard, Street and Deinard Professional Association

 150 South Fifth Street, Suite 2300 
 Minneapolis, MN 55402 
 ARTICLE VI 
 STOCKHOLDER ACTION 
 1. Action without Meeting. Except as otherwise provided herein, any
action required or permitted to be taken by the stockholders of the Corporation at any annual or special meeting of stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders and may not be taken or
effected by a written consent of stockholders in lieu thereof. 
 2. Special Meetings. Except as otherwise required by statute,
special meetings of the stockholders of the Corporation may be called only by the Board of Directors acting pursuant to a resolution approved by the affirmative vote of a majority of the Directors then in office. Only those matters set forth in the
notice of the special meeting may be considered or acted upon at a special meeting of stockholders of the Corporation. 
 ARTICLE VII

 DIRECTORS 
 1.
General. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors except as otherwise provided herein or required by law. 
  

 2 

 2. Election of Directors. Election of Directors need not be by written ballot unless the By-laws
of the Corporation (the “By-laws”) shall so provide. 
 3. Number of Directors; Term of Office. The number of Directors of
the Corporation shall be fixed solely and exclusively by resolution duly adopted from time to time by the Board of Directors. The Directors shall be classified, with respect to the term for which they severally hold office, into three classes, as
nearly equal in number as reasonably possible. The initial Class I Director of the Corporation shall be Dr. Paul K. Wotton; the initial Class II Directors of the Corporation shall be Jack E. Stover and Anton Gueth; and the initial Class
III Directors of the Corporation shall be Dr. Jacques Gonella, Thomas J. Garrity and Dr. Rajesh C. Shrotriya. The initial Class I Directors shall serve for a term expiring at the annual meeting of stockholders to be held in 2008, the
initial Class II Directors shall serve for a term expiring at the annual meeting of stockholders to be held in 2006, and the initial Class III Directors shall serve for a term expiring at the annual meeting of stockholders to be held in 2007. At
each annual meeting of stockholders, Directors elected to succeed those Directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election. Notwithstanding the
foregoing, the Directors elected to each class shall hold office until their successors are duly elected and qualified or until their earlier resignation or removal. 
 4. Vacancies. Any and all vacancies in the Board of Directors, however occurring, including, without limitation, by reason of an increase in size of the Board of Directors, or the death, resignation,
disqualification or removal of a Director, shall be filled solely and exclusively by the affirmative vote of a majority of the remaining Directors then in office, even if less than a quorum of the Board of Directors, and not by the stockholders. Any
Director appointed in accordance with the preceding sentence shall hold office for the remainder of the full term of the class of Directors in which the new directorship was created or the vacancy occurred and until such Director’s successor
shall have been duly elected and qualified or until his or her earlier resignation or removal. When the number of Directors is increased or decreased, the Board of Directors shall, subject to Article VII.3 hereof, determine the class or classes to
which the increased or decreased number of Directors shall be apportioned; provided, however, that no decrease in the number of Directors shall shorten the term of any incumbent Director. In the event of a vacancy in the Board of Directors, the
remaining Directors, except as otherwise provided by law, shall exercise the powers of the full Board of Directors until the vacancy is filled. 
 5. Removal. Any Director (including persons elected by Directors to fill vacancies in the Board of Directors) may be removed from office (i) only with cause and (ii) only by the affirmative vote of the holders of 70% or
more of the shares then entitled to vote at an election of Directors. At least forty-five (45) days prior to any meeting of stockholders at which it is proposed that any Director be removed from office, written notice of such proposed removal
and the alleged grounds thereof shall be sent to the Director whose removal will be considered at the meeting. 
 ARTICLE VIII

 LIMITATION OF LIABILITY 
 A Director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a Director, except for liability (a) for any breach of the Director’s duty of
loyalty to the Corporation or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) under Section 174 of the DGCL or (d) for any transaction from
which the Director derived an 

  

 3 

 
improper personal benefit. If the DGCL is amended after the effective date of this Certificate to authorize corporate action further eliminating or limiting
the personal liability of Directors, then the liability of a Director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. 
 Any repeal or modification of this Article VIII by either of (i) the stockholders of the Corporation or (ii) an amendment to the DGCL, shall
not adversely affect any right or protection existing at the time of such repeal or modification with respect to any acts or omissions occurring before such repeal or modification of a person serving as a Director at the time of such repeal or
modification. 
 ARTICLE IX 
 AMENDMENT OF BY-LAWS 
 1. Amendment by Directors. Except as otherwise provided by law, the By-laws of the Corporation
may be amended or repealed by the Board of Directors by the affirmative vote of a majority of the Directors then in office. 
 2.
Amendment by Stockholders. The By-laws of the Corporation may be amended or repealed at any annual meeting of stockholders, or special meeting of stockholders called for such purpose as provided in the By-laws, by the affirmative vote of at
least 70% of the outstanding shares entitled to vote on such amendment or repeal, voting together as a single class; provided, however, that if the Board of Directors recommends that stockholders approve such amendment or repeal at such meeting of
stockholders, such amendment or repeal shall only require the affirmative vote of the majority of the outstanding shares entitled to vote on such amendment or repeal, voting together as a single class. 
 ARTICLE X 
 AMENDMENT OF CERTIFICATE
OF INCORPORATION 
 The Corporation reserves the right to amend or repeal this Certificate in the manner now or hereafter prescribed by
statute and this Certificate, and all rights conferred upon stockholders herein are granted subject to this reservation. Whenever any vote of the holders of voting stock is required to amend or repeal any provision of this Certificate, and in
addition to any other vote of holders of voting stock that is required by this Certificate or by law, such amendment or repeal shall require the affirmative vote of the majority of the outstanding shares entitled to vote on such amendment or repeal,
and the affirmative vote of the majority of the outstanding shares of each class entitled to vote thereon as a class, at a duly constituted meeting of stockholders called expressly for such purpose; provided, however, that the affirmative vote of
not less than 70% of the outstanding shares entitled to vote on such amendment or repeal, and the affirmative vote of not less than 70% of the outstanding shares of each class entitled to vote thereon as a class, shall be required to amend or repeal
any provision of Article VI, Article VII, Article VIII, Article IX or Article X of this Certificate. 
 [End of Text] 
  

 4 

 IN WITNESS WHEREOF, THIS CERTIFICATE OF INCORPORATION is executed as of this _____ day of April, 2005.

  

	
	 INCORPORATOR:

	
	   
	 Jeffrey L. Cotter

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]